Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
2.

A free and simple computerized screening test for visual field defects.

Nordfang M, Uhre V, Robotham RJ, Kerry SJ, Frederiksen JL, Starrfelt R.

Scand J Psychol. 2019 May 26. doi: 10.1111/sjop.12546. [Epub ahead of print]

PMID:
31131452
3.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
4.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

PMID:
30587516
5.

Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.

Lundqvist S, Modvig S, Fischer EA, Frederiksen JL, Degn M.

Immunology. 2019 Mar;156(3):259-269. doi: 10.1111/imm.13024. Epub 2018 Dec 27.

PMID:
30452090
6.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

7.

The role of gluten in multiple sclerosis: A systematic review.

Thomsen HL, Jessen EB, Passali M, Frederiksen JL.

Mult Scler Relat Disord. 2019 Jan;27:156-163. doi: 10.1016/j.msard.2018.10.019. Epub 2018 Oct 23.

PMID:
30384202
8.

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study).

Pedersen ED, Stenager E, Vadgaard JL, Jensen MB, Schmid R, Meland N, Magnussen G, Frederiksen JL.

Patient Prefer Adherence. 2018 Apr 19;12:569-575. doi: 10.2147/PPA.S154417. eCollection 2018.

9.

Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis.

Rasul T, Frederiksen JL.

J Neurol. 2018 Dec;265(12):2755-2763. doi: 10.1007/s00415-018-8869-9. Epub 2018 Apr 26. Review.

PMID:
29700643
10.

Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.

Cramer SP, Simonsen HJ, Varatharaj A, Galea I, Frederiksen JL, Larsson HBW.

Ann Neurol. 2018 May;83(5):902-914. doi: 10.1002/ana.25219. Epub 2018 May 11.

11.

Optical coherence tomography in multiple sclerosis.

Britze J, Frederiksen JL.

Eye (Lond). 2018 May;32(5):884-888. doi: 10.1038/s41433-017-0010-2. Epub 2018 Feb 2. Review.

12.

The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis.

Bisgaard AK, Pihl-Jensen G, Frederiksen JL.

Mult Scler Relat Disord. 2017 Nov;18:213-217. doi: 10.1016/j.msard.2017.10.009. Epub 2017 Oct 13.

PMID:
29141813
13.

Vaccines and multiple sclerosis.

Frederiksen JL, Topsøe Mailand M.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:49-51. doi: 10.1111/ane.12837. Review.

PMID:
29068486
14.

Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.

Britze J, Pihl-Jensen G, Frederiksen JL.

J Neurol. 2017 Sep;264(9):1837-1853. doi: 10.1007/s00415-017-8531-y. Epub 2017 May 31. Review.

PMID:
28567539
15.

Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: A review.

Pihl-Jensen G, Schmidt MF, Frederiksen JL.

Clin Neurophysiol. 2017 Jul;128(7):1234-1245. doi: 10.1016/j.clinph.2017.03.047. Epub 2017 Apr 11. Review.

PMID:
28531809
16.

Vaccines and multiple sclerosis: a systematic review.

Mailand MT, Frederiksen JL.

J Neurol. 2017 Jun;264(6):1035-1050. doi: 10.1007/s00415-016-8263-4. Epub 2016 Sep 7. Review.

PMID:
27604618
17.

Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.

Dalbjerg SM, Tsakiri A, Frederiksen JL.

Mult Scler Relat Disord. 2016 Jul;8:93-5. doi: 10.1016/j.msard.2016.05.005. Epub 2016 May 16.

PMID:
27456881
18.

Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Bredholt M, Frederiksen JL.

ASN Neuro. 2016 Jun 9;8(3). pii: 1759091416651511. doi: 10.1177/1759091416651511. Print 2016 Jun. Review.

19.

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.

Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P; IMSVISUAL consortium.

Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18.

PMID:
27011339
20.

Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.

Møllgaard M, Degn M, Sellebjerg F, Frederiksen JL, Modvig S.

Eur J Neurol. 2016 May;23(5):898-905. doi: 10.1111/ene.12960. Epub 2016 Feb 12.

PMID:
26872061
21.

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.

Sørensen PS, Sellebjerg F, Lycke J, Färkkilä M, Créange A, Lund CG, Schluep M, Frederiksen JL, Stenager E, Pfleger C, Garde E, Kinnunen E, Marhardt K; RECYCLINE Study Investigators.

Eur J Neurol. 2016 May;23(5):861-70. doi: 10.1111/ene.12953. Epub 2016 Feb 5.

PMID:
26848561
22.

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F; MAGNIMS Study Group.

Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26. Review.

23.

Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.

Degn M, Modvig S, Dyring-Andersen B, Bonefeld CM, Frederiksen JL, Geisler C, von Essen MR.

Mult Scler. 2016 Jul;22(8):1013-20. doi: 10.1177/1352458515609795. Epub 2015 Oct 9.

PMID:
26453677
24.

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.

Modvig S, Degn M, Sander B, Horwitz H, Wanscher B, Sellebjerg F, Frederiksen JL.

Mult Scler. 2016 Apr;22(5):590-8. doi: 10.1177/1352458515599074. Epub 2015 Aug 17.

PMID:
26283696
25.

Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.

Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HB.

Brain. 2015 Sep;138(Pt 9):2571-83. doi: 10.1093/brain/awv203. Epub 2015 Jul 17.

26.

25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis.

Pihl-Jensen G, Frederiksen JL.

J Neurol. 2015 Jul;262(7):1646-54. doi: 10.1007/s00415-015-7740-5. Epub 2015 May 1.

PMID:
25929657
27.

Statin treatment in multiple sclerosis: a systematic review and meta-analysis.

Pihl-Jensen G, Tsakiri A, Frederiksen JL.

CNS Drugs. 2015 Apr;29(4):277-91. doi: 10.1007/s40263-015-0239-x. Review.

PMID:
25795002
28.

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.

Modvig S, Degn M, Roed H, Sørensen TL, Larsson HB, Langkilde AR, Frederiksen JL, Sellebjerg F.

Mult Scler. 2015 Dec;21(14):1761-70. doi: 10.1177/1352458515574148. Epub 2015 Feb 19.

PMID:
25698172
29.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G.

Mult Scler. 2015 Jul;21(8):1013-24. doi: 10.1177/1352458514568827. Epub 2015 Feb 13.

PMID:
25680984
30.

Neuroprotective and anti-inflammatory mechanisms are activated early in optic neuritis.

Tsakiri A, Ravanidis S, Lagoudaki R, Poulatsidou KN, Svane IM, Frederiksen JL, Grigoriadis N.

Acta Neurol Scand. 2015 May;131(5):305-12. doi: 10.1111/ane.12344. Epub 2015 Jan 7.

PMID:
25565254
31.

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, Correia de Sá J, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7. No abstract available.

32.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. Erratum in: J Neurol. 2015 Jan;262(1):248.

33.

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.

Matthews L, Enzinger C, Fazekas F, Rovira A, Ciccarelli O, Dotti MT, Filippi M, Frederiksen JL, Giorgio A, Küker W, Lukas C, Rocca MA, De Stefano N, Toosy A, Yousry T, Palace J; MAGNIMS Network.

J Neurol Neurosurg Psychiatry. 2015 May;86(5):537-42. doi: 10.1136/jnnp-2014-308186. Epub 2014 Jul 22.

34.

B cell follicle-like structures in multiple sclerosis-with focus on the role of B cell activating factor.

Haugen M, Frederiksen JL, Degn M.

J Neuroimmunol. 2014 Aug 15;273(1-2):1-7. doi: 10.1016/j.jneuroim.2014.05.010. Epub 2014 May 27. Review.

PMID:
24953530
35.

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.

Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E, Green AJ, Klistorner A, Outteryck O, Paul F, Plant GT, Traber G, Vermersch P, Villoslada P, Wolf S, Petzold A.

Mult Scler. 2015 Feb;21(2):163-70. doi: 10.1177/1352458514538110. Epub 2014 Jun 16.

PMID:
24948688
36.

Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.

Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Khalil M, Rocca MA, Sprenger T, Amann M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F.

Mult Scler. 2014 Nov;20(13):1692-8. doi: 10.1177/1352458514531085. Epub 2014 Apr 30.

PMID:
24787429
37.

Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.

Cramer SP, Simonsen H, Frederiksen JL, Rostrup E, Larsson HB.

Neuroimage Clin. 2013 Dec 10;4:182-9. doi: 10.1016/j.nicl.2013.12.001. eCollection 2014.

38.

Differential diagnoses to MS: experiences from an optic neuritis clinic.

Horwitz H, Friis T, Modvig S, Roed H, Tsakiri A, Laursen B, Frederiksen JL.

J Neurol. 2014 Jan;261(1):98-105. doi: 10.1007/s00415-013-7166-x. Epub 2013 Oct 25.

PMID:
24158275
39.

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis.

Modvig S, Degn M, Horwitz H, Cramer SP, Larsson HB, Wanscher B, Sellebjerg F, Frederiksen JL.

PLoS One. 2013 Oct 8;8(10):e77163. doi: 10.1371/journal.pone.0077163. eCollection 2013.

40.

Detection of antibodies to the 20s proteasome by ELISA.

Jørgensen KM, Frederiksen JL, Nielsen CT, Houen G.

J Immunoassay Immunochem. 2013;34(4):384-92. doi: 10.1080/15321819.2012.755628.

PMID:
23859789
41.

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.

Teunissen C, Menge T, Altintas A, Álvarez-Cermeño JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A.

Mult Scler. 2013 Nov;19(13):1802-9. doi: 10.1177/1352458513488232. Epub 2013 May 21.

PMID:
23695446
42.

Multicenter R2* mapping in the healthy brain.

Ropele S, Wattjes MP, Langkammer C, Kilsdonk ID, Graaf WL, Frederiksen JL, Fuglø D, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Rocca MA, Sprenger T, Amman M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F.

Magn Reson Med. 2014 Mar;71(3):1103-7. doi: 10.1002/mrm.24772.

43.

Immune system alterations in amyotrophic lateral sclerosis.

Hovden H, Frederiksen JL, Pedersen SW.

Acta Neurol Scand. 2013 Nov;128(5):287-96. doi: 10.1111/ane.12125. Epub 2013 Apr 1. Review.

PMID:
23550891
44.

The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.

Jennum P, Frederiksen JL, Wanscher B, Kjellberg J.

Acta Neurol Scand. 2013 Apr;127(4):242-50. doi: 10.1111/j.1600-0404.2012.01703.x. Epub 2012 Jul 20.

PMID:
22812660
45.

CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.

Horwitz H, Degn M, Modvig S, Larsson HB, Wanscher B, Frederiksen JL.

J Neurol. 2012 Dec;259(12):2616-20. doi: 10.1007/s00415-012-6551-1. Epub 2012 Jun 6.

PMID:
22669354
46.

Effector and regulatory T cells in patients with acute optic neuritis.

Tsakiri A, Kjærsgaard E, Grigoriadis N, Svane IM, Frederiksen JL.

Neuroimmunomodulation. 2012;19(2):111-20. doi: 10.1159/000330242. Epub 2012 Jan 11.

PMID:
22248727
47.

Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.

Beyer NH, Lueking A, Kowald A, Frederiksen JL, Heegaard NH.

J Neuroimmunol. 2012 Jan 18;242(1-2):26-32. doi: 10.1016/j.jneuroim.2011.08.013. Epub 2011 Dec 15.

PMID:
22177943
48.

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.

Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB; SIMCOMBIN study investigators.

Lancet Neurol. 2011 Aug;10(8):691-701. doi: 10.1016/S1474-4422(11)70144-2.

PMID:
21742556
49.

Oligoclonal bands predict multiple sclerosis after optic neuritis: a literature survey.

Skov AG, Skov T, Frederiksen JL.

Mult Scler. 2011 Apr;17(4):404-10. doi: 10.1177/1352458510391340. Epub 2010 Dec 15. Review.

PMID:
21159718
50.

Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.

Kallenbach K, Sander B, Tsakiri A, Wanscher B, Fuglø D, Larsen M, Larsson H, Frederiksen JL.

Mult Scler. 2011 Jan;17(1):89-95. doi: 10.1177/1352458510382017. Epub 2010 Sep 16.

PMID:
20847000

Supplemental Content

Loading ...
Support Center